Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cipla
Chubb
Daiichi Sankyo
Accenture
Argus Health
Queensland Health
Chinese Patent Office
Fuji
Fish and Richardson

Generated: October 19, 2017

DrugPatentWatch Database Preview

Glimepiride; rosiglitazone maleate - Generic Drug Details

« Back to Dashboard

What are the generic sources for glimepiride; rosiglitazone maleate and what is the scope of glimepiride; rosiglitazone maleate patent protection?

Glimepiride; rosiglitazone maleate
is the generic ingredient in two branded drugs marketed by Sb Pharmco and Teva Pharms Usa, and is included in two NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for glimepiride; rosiglitazone maleate.

Summary for Generic Name: glimepiride; rosiglitazone maleate

US Patents:1
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list14
Clinical Trials: see list555
Drug Prices:see low prices
DailyMed Link:glimepiride; rosiglitazone maleate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-004Mar 30, 2007DISCNYesNo► Subscribe► SubscribeY► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-003Apr 1, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-005Mar 30, 2007DISCNYesNo► Subscribe► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-003Nov 23, 2005DISCNYesNo► Subscribe► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-002Nov 23, 2005DISCNYesNo► Subscribe► SubscribeY► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-005Apr 1, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-001Apr 1, 2016RXNoYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-002Apr 1, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-004Apr 1, 2016RXNoNo► Subscribe► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 2005DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: glimepiride; rosiglitazone maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-004Mar 30, 2007► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 2005► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-005Mar 30, 2007► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-002Nov 23, 2005► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-002Nov 23, 2005► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-003Nov 23, 2005► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 2005► Subscribe► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-003Nov 23, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
AstraZeneca
UBS
Accenture
US Department of Justice
Fish and Richardson
Argus Health
Cerilliant
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot